BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 23740839)

  • 1. Correlating transcriptional networks to breast cancer survival: a large-scale coexpression analysis.
    Clarke C; Madden SF; Doolan P; Aherne ST; Joyce H; O'Driscoll L; Gallagher WM; Hennessy BT; Moriarty M; Crown J; Kennedy S; Clynes M
    Carcinogenesis; 2013 Oct; 34(10):2300-8. PubMed ID: 23740839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Wilms' tumor 1 mRNA expression correlates with basal-like and ERBB2 molecular subtypes and poor prognosis of breast cancer.
    Qi XW; Zhang F; Yang XH; Fan LJ; Zhang Y; Liang Y; Ren L; Zhong L; Chen QQ; Zhang KY; Zang WD; Wang LS; Zhang Y; Jiang J
    Oncol Rep; 2012 Oct; 28(4):1231-6. PubMed ID: 22797561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PIK3CA expression in invasive breast cancer: a biomarker of poor prognosis.
    Aleskandarany MA; Rakha EA; Ahmed MA; Powe DG; Paish EC; Macmillan RD; Ellis IO; Green AR
    Breast Cancer Res Treat; 2010 Jul; 122(1):45-53. PubMed ID: 19701705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prognostic model for lymph node-negative breast cancer patients based on the integration of proliferation and immunity.
    Oh E; Choi YL; Park T; Lee S; Nam SJ; Shin YK
    Breast Cancer Res Treat; 2012 Apr; 132(2):499-509. PubMed ID: 21667120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of a co‑expression network for the analysis of aggressive and non‑aggressive breast cancer cell lines to predict the clinical outcome of patients.
    Guo L; Zhang K; Bing Z
    Mol Med Rep; 2017 Dec; 16(6):7967-7978. PubMed ID: 28944917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges in projecting clustering results across gene expression-profiling datasets.
    Lusa L; McShane LM; Reid JF; De Cecco L; Ambrogi F; Biganzoli E; Gariboldi M; Pierotti MA
    J Natl Cancer Inst; 2007 Nov; 99(22):1715-23. PubMed ID: 18000217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a gene module associated with BMD through the integration of network analysis and genome-wide association data.
    Farber CR
    J Bone Miner Res; 2010 Nov; 25(11):2359-67. PubMed ID: 20499364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression.
    Anders CK; Hsu DS; Broadwater G; Acharya CR; Foekens JA; Zhang Y; Wang Y; Marcom PK; Marks JR; Febbo PG; Nevins JR; Potti A; Blackwell KL
    J Clin Oncol; 2008 Jul; 26(20):3324-30. PubMed ID: 18612148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic evaluation of the B cell/IL-8 metagene in different intrinsic breast cancer subtypes.
    Hanker LC; Rody A; Holtrich U; Pusztai L; Ruckhaeberle E; Liedtke C; Ahr A; Heinrich TM; Sänger N; Becker S; Karn T
    Breast Cancer Res Treat; 2013 Jan; 137(2):407-16. PubMed ID: 23242614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes.
    Carey LA; Dees EC; Sawyer L; Gatti L; Moore DT; Collichio F; Ollila DW; Sartor CI; Graham ML; Perou CM
    Clin Cancer Res; 2007 Apr; 13(8):2329-34. PubMed ID: 17438091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
    Sanpaolo P; Barbieri V; Genovesi D
    Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Claudins as prognostic factors of breast cancer].
    Szász MA
    Magy Onkol; 2012 Sep; 56(3):209-12. PubMed ID: 23139925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation of metastasis-free survival in patients with breast cancer and changes in the direction of expression of multidrug resistance genes during neoadjuvant chemotherapy].
    Litviakov NV; Garbukov EIu; Slonimskaia EM; Tsyganov MM; Denisov EV; Vtorushin SV; Khristenko KIu; Zav'ialova MV; Cherdyntseva NV
    Vopr Onkol; 2013; 59(3):334-40. PubMed ID: 23909034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annexin A8 is up-regulated during mouse mammary gland involution and predicts poor survival in breast cancer.
    Stein T; Price KN; Morris JS; Heath VJ; Ferrier RK; Bell AK; Pringle MA; Villadsen R; Petersen OW; Sauter G; Bryson G; Mallon EA; Gusterson BA
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6872-9. PubMed ID: 16203777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients.
    Györffy B; Lanczky A; Eklund AC; Denkert C; Budczies J; Li Q; Szallasi Z
    Breast Cancer Res Treat; 2010 Oct; 123(3):725-31. PubMed ID: 20020197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling.
    Azim HA; Michiels S; Bedard PL; Singhal SK; Criscitiello C; Ignatiadis M; Haibe-Kains B; Piccart MJ; Sotiriou C; Loi S
    Clin Cancer Res; 2012 Mar; 18(5):1341-51. PubMed ID: 22261811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer.
    Bergamaschi A; Kim YH; Wang P; Sørlie T; Hernandez-Boussard T; Lonning PE; Tibshirani R; Børresen-Dale AL; Pollack JR
    Genes Chromosomes Cancer; 2006 Nov; 45(11):1033-40. PubMed ID: 16897746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
    Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer.
    Jézéquel P; Campone M; Gouraud W; Guérin-Charbonnel C; Leux C; Ricolleau G; Campion L
    Breast Cancer Res Treat; 2012 Feb; 131(3):765-75. PubMed ID: 21452023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a transcriptional signature of breast cancer.
    Feng Y; Li X; Sun B; Wang Y; Zhang L; Pan X; Chen X; Wang X; Wang J; Hao X
    Breast Cancer Res Treat; 2010 Jul; 122(1):65-75. PubMed ID: 19728083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.